Showing 91-105 of 543
-
Invited Perspective: Per- and Polyfluoroalkyl Substances and Impaired Antibody Response to Vaccination-Who Is Affected?
Science
14 Aug 2023 | Environ Health Perspect
The role of factors like age, adverse experiences, and different life stages in PFAS-exposure immunotoxicity is a critical unanswered question, particularly involving COVID-19 vaccine response in the limited study cohort in Andersson et al., 2023.
-
High Exposure to Perfluoroalkyl Substances and Antibody Responses to SARS-CoV-2 mRNA Vaccine-an Observational Study in Adults from Ronneby, Sweden
Science
14 Aug 2023 | Environ Health Perspect
High levels of PFAS exposure were found not to impair the COVID-19 mRNA vaccine response for up to 6 months after the shot.
-
Per- and Polyfluoroalkyl Substances (PFAS) and Lipid Trajectories in Women 45-56 Years of Age: The Study of Women's Health Across the Nation
Science
8 Aug 2023 | Environ Health Perspect
Research conducted among midlife women revealed a correlation between specific PFAS and elevated cholesterol levels in the bloodstream, characterized by a distinctive pattern of rapid increase followed by a decrease.
-
Exposure characteristics of legacy and novel per- and polyfluoroalkyl substances in blood and association with hypertension among low-exposure population
Science
29 Jul 2023 | J Hazard Mater
Among participants with low levels of PFAS exposure, PFHxA showed a positive association with risk of hypertension, while a novel PFAS, 6:2 Cl-PFESA, showed a negative association.
-
Fetal Glucocorticoid Mediates the Association between Prenatal Per- and Polyfluoroalkyl Substance Exposure and Neonatal Growth Index: Evidence from a Birth Cohort Study
Science
26 Jul 2023 | Environ Sci Technol
Fetal hormone levels were found to influence the association between mothers’ PFAS levels and fetal growth.
-
Per- and polyfluoroalkyl substances in ambient fine particulate matter in the Pearl River Delta, China: Levels, distribution and health implications
Science
25 Jul 2023 | Env Poll
PFAS exposure via inhalation of particulate matter was found to be dominated by low levels of PFSAs and PFCAs, but inhalation exposure is still important due to its long-term and cumulative nature.
-
Examining the impact of nanoplastics and PFAS exposure on immune functions through inhibition of secretory immunoglobin A in human breast milk
Science
22 Jul 2023 | J Hazard Mater
The presence of nanoplastics and PFAS in breast milk was computationally found to likely impair infants’ immune systems.
-
Dingell Leads Introduction of Bipartisan Legislation to Remove PFAS from Firefighter Gear
Policy
20 Jul 2023
Bipartisan Congresspeople introduced The Protecting Firefighters and Advancing State-of-the-Art Alternatives Act (PFAS Alternatives Act), to support development of next-generation PFAS-free turnout gear for firefighters and better protect firefighters from the dangers of their work.
-
Current Review of Increasing Animal Health Threat of Per- and Polyfluoroalkyl Substances (PFAS): Harms, Limitations, and Alternatives to Manage Their Toxicity
Science
20 Jul 2023 | Int J Mol Sci
The review highlights the persistence of PFAS in the environment, their potential health effects on both humans and animals, and the need for further research and countermeasures to mitigate their impact, especially on animals.
-
Environmental exposure and ecological risk of perfluorinated substances (PFASs) in the Shaying River Basin, China
Science
19 Jul 2023 | Chemosphere
PFAS exposure via inhalation of particulate matter was found to be dominated by low levels of PFSAs and PFCAs, but inhalation exposure is still important due to its long-term and cumulative nature.
-
A State-of-the-Science Review of Interactions of Per-and Polyfluoroalkyl Substances (PFAS) with Renal Transporters in Health and Disease: Implications for Population Variability in PFAS Toxicokinetics
Science
13 Jul 2023 | Environ Health Perspect.
This state-of-the-science review integrated current knowledge to assess how changes in kidney function and transporter expression from health to disease could affect PFAS toxicokinetics and identified priority research gaps that should be addressed to advance knowledge.
-
‘Forever Chemical’ Lawsuits Could Ultimately Eclipse the Big Tobacco Settlement
News
13 Jul 2023 | TIME
So far, DuPont, Chemours, Corteva, and 3M have paid a total of nearly $11.5 billion in damages for PFAS contamination. But that number could grow considerably, even exceeding the more than $200 billion paid by Big Tobacco in the 1990s.
-
Research Progress on Neurodevelopmental Toxicity in Offspring after Indirect Exposure to PFASs in Early Life
Science
30 Jun 2023 | MDPI
According to available scientific literature, early life exposure to PFAS may result in neurodevelopmental toxicity through oxidative stress and the development of abnormal nerve cells.
-
Prenatal exposure to per- and polyfluoroalkyl substances and infant sleep disturbance: A prospective cohort study
Science
28 Jun 2023 | Environ Int
Exposure to several PFAS was significantly associated with an increased risk of sleep disturbance in infants, including nighttime awakenings, snoring, and longer nocturnal wakefulness.
-
Plasma concentrations of per- and polyfluoroalkyl substances in pregnancy and breastfeeding duration in Project Viva
Science
19 Jun 2023 | Sci. Tot. Env.
Higher plasma PFAS in pregnancy was associated with shorter breastfeeding duration.